SLE patients. Use of HRT in symptomatic postmenopausal SLE patients may raise concerns regarding increased risk of flare and/or thrombosis; however, HRT use in aPL-negative women with quiescent SLE may be considered. In SLE patients without positive aPL who desire HRT due to severe vasomotor symptoms and have no contraindications, we conditionally recommend HRT treatment. Moderate-quality direct evidence supports use of oral HRT in aPL-negative women with SLE who have stable low-level disease